Professor Ian O. Ellis
Vice President for Healthcare Outcomes Policy and
Oncology and Molecular Radiation Sciences
University of Nottingham, UK.
Norway
Biography
Professor Ian O. Ellis has been involved in the practice of pathology for over thirty years and has an international reputation in clinical and translational research in breast disease, particularly classification of breast cancer and evaluation of prognostic factors. Author of over 600 peer reviewed scientific publications, chapters in medical textbooks and specialist textbooks in pathology and an experienced lecturer being a founder member of the faculty of the Nottingham International Breast Education Centre. He is a Fellow and a past Specialty Advisor of The Royal College of Pathologists, past President of the Pathological Socity of Great Britain and Ireland, Past Chairman of the UK National Co-ordinating Committee for Breast Pathology, Past President of the International Society of Breast Pathology, past Councilor of The European Society of Mastology, Steering Committee Member of The European Group for Breast Screening Pathology and past Chairman of the Breast Pathology Working Group of the European Society of Pathology. He has acted as an advisor to theDoH, UICC, WHO and IARC. He is founder of PathLore and Medical Director of Source Bioscience.
Research Interest
The Nottingham/Tenovus Breast Cancer Research Group at Nottingham City Hospital has a longstanding research interest and international track record in classification of breast cancer
Publications
-
CURTIS, C., SHAH, S.P., CHIN, S., TURASHVILI, G., RUEDA, O.M., DUNNING, M.J., SPEED, D., LYNCH, A.G., SAMARAJIWA, S., YUAN, Y., GRAF, S., HA, G., HAFFARI, G., BASHASHATI, A., RUSSELL, R., MCKINNEY, S., METABRIC GROUP, LANGEROD, A., GREEN, A., PROVENZANO, E., WISHART, G., PINDER, S., WATSON, P., MARKOWETZ, F., MURPHY, L., ELLIS, I., PURUSHOTHAM, A., BORRESEN-DAL, A., BRENTON, J.D., TAVARE, S., CALDAS, C. and APARACIO, S., 2012. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups Nature. 486(7403), 346-352 ROSS-INNES, C.S., STARK, R., TESCHENDORFF, A.E., HOLMES, K.A., ALI, H.R., DUNNING, M.J., BROWN, G.D., GOJIS, O., ELLIS, I.O., GREEN, A.R., ALI, S., CHIN, S., PALMIERI, C., CALDAS, C. and CARROLL, J.S., 2012. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer Nature. 481(7381), 389-393 GIAMAS, G., FILIPOVIĆ, A., JACOB, J., MESSIER, W., ZHANG, H., YANG, D., ZHANG, W., SHIFA, B.A., PHOTIOU, A., TRALAU-STEWART, C., CASTELLANO, L., GREEN, A.R., COOMBES, R.C., ELLIS, I.O., ALI, S., LENZ, H.J. and STEBBING, J., 2011. Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer Nature Medicine. 17(6), 715-719 CUZICK, J., SESTAK, I., PINDER, S.E., ELLIS, I.O., FORSYTH, S., BUNDRED, N.J., FORBES, J.F., BISHOP, H., FENTIMAN, I.S. and GEORGE, W.D., 2011. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial Lancet Oncology. 12(1), 21-29
-
CURTIS, C., SHAH, S.P., CHIN, S., TURASHVILI, G., RUEDA, O.M., DUNNING, M.J., SPEED, D., LYNCH, A.G., SAMARAJIWA, S., YUAN, Y., GRAF, S., HA, G., HAFFARI, G., BASHASHATI, A., RUSSELL, R., MCKINNEY, S., METABRIC GROUP, LANGEROD, A., GREEN, A., PROVENZANO, E., WISHART, G., PINDER, S., WATSON, P., MARKOWETZ, F., MURPHY, L., ELLIS, I., PURUSHOTHAM, A., BORRESEN-DAL, A., BRENTON, J.D., TAVARE, S., CALDAS, C. and APARACIO, S., 2012. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups Nature. 486(7403), 346-352 ROSS-INNES, C.S., STARK, R., TESCHENDORFF, A.E., HOLMES, K.A., ALI, H.R., DUNNING, M.J., BROWN, G.D., GOJIS, O., ELLIS, I.O., GREEN, A.R., ALI, S., CHIN, S., PALMIERI, C., CALDAS, C. and CARROLL, J.S., 2012. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer Nature. 481(7381), 389-393 GIAMAS, G., FILIPOVIĆ, A., JACOB, J., MESSIER, W., ZHANG, H., YANG, D., ZHANG, W., SHIFA, B.A., PHOTIOU, A., TRALAU-STEWART, C., CASTELLANO, L., GREEN, A.R., COOMBES, R.C., ELLIS, I.O., ALI, S., LENZ, H.J. and STEBBING, J., 2011. Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer Nature Medicine. 17(6), 715-719 CUZICK, J., SESTAK, I., PINDER, S.E., ELLIS, I.O., FORSYTH, S., BUNDRED, N.J., FORBES, J.F., BISHOP, H., FENTIMAN, I.S. and GEORGE, W.D., 2011. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial Lancet Oncology. 12(1), 21-29
